Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company WuXi Biologics (Cayman) Inc. Hong Kong S.E.

Equities

2269

KYG970081090

Biotechnology & Medical Research

Business Summary

WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development, late-phase (phase III) clinical development and commercial manufacturing. The Company also offers end-to-end vaccine CRDMO services, including vaccine discovery and development, scale-up commercial manufacturing and global distribution. The Company has WuXiBody bispecific antibody platform, SDArBodY multispecific antibody platform, WuXia cell line development platform, WuXiUP continuous manufacturing platform and mRNA vaccine platform. The Company mainly operates its businesses in the domestic and overseas markets.

Sales per Business

HKD in Million2022Weight2023Weight Delta
Biologics
88.8 %
2,582 14.5 % 16,717 88.8 % +547.32%
XDC
11.2 %
- - 2,106 11.2 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
North America
47.4 %
9,880 55.6 % 8,921 47.4 % -9.71%
Europe
30.2 %
2,961 16.7 % 5,681 30.2 % +91.85%
China
18.3 %
4,325 24.4 % 3,449 18.3 % -20.24%
Rest of the World
4.1 %
590 3.3 % 772 4.1 % +30.89%

Managers

Managers TitleAgeSince
Zhi Sheng Chen CEO
 Chief Executive Officer 52 01/11/01
Ming Tu DFI
 Director of Finance/CFO 54 23/21/23
Gu Jijie CTO
 Chief Tech/Sci/R&D Officer 57 -
Weichang Zhou BRD
 Director/Board Member 59 01/12/01
Yue Huang SEC
 Corporate Secretary - 20/18/20
Ying Man Sham SEC
 Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Jackson Tai BRD
 Director/Board Member 73 06/23/06
William Keller BRD
 Director/Board Member 75 17/17/17
Ge Li CHM
 Chairman 56 01/10/01
Yan Ling Cao BRD
 Director/Board Member 39 01/16/01
Yi Bing Wu BRD
 Director/Board Member 55 01/16/01
Zhi Sheng Chen CEO
 Chief Executive Officer 52 01/11/01
Weichang Zhou BRD
 Director/Board Member 59 01/12/01
Kenneth Hitchner BRD
 Director/Board Member 63 09/20/09
Jue Chen BRD
 Director/Board Member 54 16/23/16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,278,486,692 3,656,877,175 ( 85.47 %) 17,642,323 ( 0.4123 %) 85.47 %

Shareholders

NameEquities%Valuation
Wuxi Biologics Holdings Ltd.
13.86 %
590,257,633 13.86 % 1 037 M $
Biologics Holdings
13.72 %
584,191,133 13.72 % 1 026 M $
Capital Research & Management Co. (World Investors)
4.753 %
202,451,467 4.753 % 356 M $
BlackRock Fund Advisors
1.593 %
67,847,000 1.593 % 119 M $
BlackRock Advisors (UK) Ltd.
1.499 %
63,839,041 1.499 % 112 M $
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.7452 %
31,741,635 0.7452 % 56 M $
Bank of Communications Schroder Fund Management Co., Ltd.
0.7107 %
30,271,490 0.7107 % 53 M $
JPMorgan Investment Management, Inc.
0.6704 %
28,555,149 0.6704 % 50 M $
Zhong Ou Asset Management Co., Ltd
0.6380 %
27,175,169 0.6380 % 48 M $
JPMorgan Asset Management (Asia Pacific) Ltd.
0.5090 %
21,679,639 0.5090 % 38 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000786 %
16,738 0.000786 % 60 089 $
Lumyna Investments Ltd.
0.000195 %
4,160 0.000195 % 14 934 $
PNC Investments LLC
0.000101 %
2,145 0.000101 % 7 701 $
GAMMA Investing LLC
0.000000 %
6 0.000000 % 22 $

Company contact information

Wuxi Biologics (Cayman), Inc.

108, Meiliang Road Mashan

214092, Wuxi

+

http://www.wuxibiologics.com
address WuXi Biologics (Cayman) Inc.(2269)

Group companies

NameCategory and Sector
WuXi Biologics (Hong Kong) Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 11TCr
ARGENX SE Stock argenx SE
-1.05% 2.2TCr
BIONTECH SE Stock BioNTech SE
-14.15% 2.18TCr
GENMAB A/S Stock Genmab A/S
-5.29% 1.92TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 1.81TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 1.77TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 1.43TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 1.24TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. 2269 Stock
  5. Company WuXi Biologics (Cayman) Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW